Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lianju capsule
- Development stage
- Phase 2
- Lead developer
- West China Hospital of Sichuan University
- Administration
- Oral
01
Overview
Lianju capsule is a traditional Chinese medicine (TCM) botanical formulation developed by the West China Hospital of Sichuan University. It is specifically indicated for the treatment of the common cold characterized by wind-heat syndrome in adults. The preparation is likely composed of extracts from herbs such as Forsythia (Lianqiao) and Chrysanthemum (Juhua), which are traditionally used in TCM for their heat-clearing and detoxifying properties. The drug has been evaluated in a Phase II, randomized, placebo-controlled, dose-finding clinical trial (ChiCTR-IPR-15006504) to assess its safety and efficacy in relieving symptoms like fever, sore throat, and nasal congestion associated with viral upper respiratory tract infections.
- Other names
- Lianju jiaonang连菊胶囊
Beyond the preview
Go deeper on Lianju capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lianju capsule.